PHU NGOC TRAN M.D. NPI 1891089587

NPI Information

  • NPI: 1891089587
  • Provider Name: PHU NGOC TRAN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1871 SE TIFFANY AVE STE 100
    PORT ST LUCIE, FL
    ZIP 34952
  • Phone: (772) 335-5666

Map and Directions

Get Directions

NPI Details

Phu Ngoc Tran, M.D. is a hematology and oncology internal medicine in Port St Lucie, FL with 15 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Phu Ngoc Tran, M.D. NPI is 1891089587. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2011

The provider's business location address is:

1871 SE TIFFANY AVE STE 100
PORT ST LUCIE, FL
ZIP 34952-585
Phone: (772) 335-5666
Fax: (772) 335-3781

The NPI 1891089587 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Folic acid level, serum (HCPCS:82746)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Blood test, clotting time (HCPCS:85610)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Magnesium level (HCPCS:83735)
  • Anticoagulant management of patient taking warfarin (HCPCS:93793)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Blood creatinine level (HCPCS:82565)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Liver function blood test panel (HCPCS:80076)
  • Stool analysis for blood, by peroxidase activity (HCPCS:82272)
  • Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)

The enumeration date for this NPI number is 5/31/2011 and was last updated on 5/15/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology131186OHIOYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.